Pharmaceutical Substances Syntheses, Patents, Applications - Part 109

Pharmaceutical Substances Syntheses, Patents, Applications - Part 109. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | lodamide I 1081 H2 Roney-Ni ------------- Referenced FR5 997 M Dagra appl. prior. . Formulationd tabl. 500 mg 750 mg Trade Named D Cholebrine F Cholebrine Schering USA Cholebrine Mallinckrodt Mundipharma wfm wfm wfm 1 Colebrin Schering wfm lodamide Jodamid ATC VO8AAO3 Use X-ray contrast medium RN 440-58-4 MF C12HIII3N2O4 MW EINECS 207-125-1 LD50 7 g kg M . 7 g kg R . CN 3- acetylamino -5- acetylamino methyl -2 4 6-triiodobenzoic acid meglumine salt RN 18656-21-8 MF C12HnI3N2O4 C7H17NOS MW EINECS 242-480-6 H ci2hc n oh 0 H2S04 HCI CH3COOH 3- aminamethyl- 4- chlorobenzoic acid 1 COOH 4-chloro- 2 2-dichloro-N- benzoic hydroxymethyl- acid acetamide 1082 I lodoxamic acid IV 11 H h3cvn 0 COOH 1 0 u N CH H J lodomide Reference s US 3 360 436 Eprova appl. CH-prior. . GB 1 002 344 Eprova appl. CH-prior. . DE 1 273 747 Eprova appl. CH-prior. . Formulation s amp. 300 mg 380 mg 420 mg as meglumine salt Trade Name s D Uromiro Heyden wfm Opacist . Bracco J Conraxin Takeda I Isteropac . Bracco Uromiro Bracco lodoxamic acid ATC V08AC01 Use X-ray contrast medium cholangiography RN 31127-82-9 MF C26H26I6N2O10 MW EINECS 250-478-1 LD5 i g kg M . CN 3 3 - l 16-dioxo-4 7 10 13-tetraoxahexadecane-l 16-diyl diimino bis 2 4 6-triiodobenzoic acid meglumine salt 1 2 RN 51764-33-1 MF C26H26I6N2O10 2C7H17NO5 MW EINECS 257-398-6 NC CH2 hO- o - O acrylonitrile triethylene glycol 4 7 10 13-tetrooxahexadecane-dinitrile I 1. h2so4 c2h5oh 2. NaOH 3. SOCI2 0 4 7 10 13-tetrooxahexadecanedioyl chloride 11 COOH 3-amino-2 4 6-triiodobenzoic dimethyl-ocetomide lodoxamic ocid Reference s DE 1 937 211 Bracco appl. . Formulation s amp. g g g g g as meglumine salt lofendylate I 1083 Trade Name s D Endomirabil Byk Gulden wfm I Endobil Bracco J Cholegrafin Takeda lofendylate lophendylate ATC V08AD04 Use X-ray

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
24    21    1    30-11-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.